Literature DB >> 2179066

Effect of food on H2-receptor blockade in normal subjects and duodenal ulcer patients.

H S Merki1, F Halter, C Wilder-Smith, P Allemann, L Witzel, M Kempf, J Roehmel, R P Walt.   

Abstract

Two separate studies of 24 hour intragastric acidity were carried out in normal volunteers and duodenal ulcer patients to define the interaction of food and the antisecretory effects of H2-receptor blockers. Both investigations were double blind randomised comparisons using ranitidine 300 mg with either different meal times or ad libitum snacks after an evening meal. Meals taken after drug administration nearly abolished measurable antisectory effects. Median 24 hour pH was 1.3 on placebo, 2.6 when ranitidine was administered after the evening meal and 1.9 when administered before the evening meal. Snacks taken after evening dosing with ranitidine also significantly decreased pharmacodynamic efficacy. During placebo, median night-time pH was 1.3 without snacks and 1.4 with snacks. pH rose to 5.9 during ranitidine treatment when snacks were forbidden but was only 3.1 when snacks were allowed. These findings could be of therapeutic importance and should rationalise dietary advise to patients receiving H2 blockers. The timing of drug administration can be adjusted according to individual life styles.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2179066      PMCID: PMC1378369          DOI: 10.1136/gut.31.2.148

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  7 in total

1.  Day-to-day variation of 24-hour intragastric acidity.

Authors:  H S Merki; L Witzel; R P Walt; E Cohnen; K Harre; J Heim; A Mappes; J Röhmel
Journal:  Gastroenterology       Date:  1988-04       Impact factor: 22.682

2.  Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer.

Authors:  H S Merki; L Witzel; D Kaufman; M Kempf; J Neumann; J Röhmel; R P Walt
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

3.  Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.

Authors:  D B Jones; C W Howden; D W Burget; G D Kerr; R H Hunt
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

4.  Comparison of ranitidine 300 mg twice daily, 300 mg at night and placebo on 24-hour intragastric acidity of duodenal ulcer patients.

Authors:  H S Merki; L Witzel; R P Walt; J Neumann; E Scheurle; D Kaufmann; A Mappes; J Heim; J Röhmel
Journal:  Aliment Pharmacol Ther       Date:  1987-06       Impact factor: 8.171

5.  Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.

Authors:  T Gledhill; O M Howard; M Buck; A Paul; R H Hunt
Journal:  Gut       Date:  1983-10       Impact factor: 23.059

6.  Reduction of twenty-four-hour gastric acidity with combination drug therapy in patients with duodenal ulcer.

Authors:  W L Peterson; C Barnett; M Feldman; C T Richardson
Journal:  Gastroenterology       Date:  1979-11       Impact factor: 22.682

7.  Single dose treatment with H2 receptor antagonists: is bedtime administration too late?

Authors:  H Merki; L Witzel; K Harre; E Scheurle; J Neumann; J Röhmel
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

  7 in total
  11 in total

1.  pH-feedback controlled infusions of ranitidine are no more effective than fixed-dose infusions in reducing gastric acidity and variability in antisecretory responses.

Authors:  C H Wilder-Smith; F Halter; W Häcki; H S Merki
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

2.  Tolerance to oral H2-receptor antagonists.

Authors:  C H Wilder-Smith; T Ernst; M Gennoni; B Zeyen; F Halter; H S Merki
Journal:  Dig Dis Sci       Date:  1990-08       Impact factor: 3.199

3.  Acid suppression: how much is needed?

Authors:  D G Colin-Jones
Journal:  BMJ       Date:  1990-09-22

4.  Low dose famotidine and cimetidine in single postprandial doses: a placebo controlled comparative study of overnight pH.

Authors:  T G Reilly; S G Mann; M Z Panos; R P Walt
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

5.  Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis.

Authors:  Wei-Hong Wang; Jia-Qing Huang; Ge-Fan Zheng; Harry Hua-Xiang Xia; Wai-Man Wong; Shiu-Kum Lam; Benjamin Chun-Yu Wong
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

Review 6.  Optimizing acid suppression for treatment of acid-related diseases.

Authors:  R H Hunt; C Cederberg; J Dent; F Halter; C Howden; I N Marks; S Rune; R P Walt
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

7.  Problems with the interpretation of gastric pH measurement.

Authors:  D A Johnston; K G Wormsley
Journal:  Clin Investig       Date:  1993-12

8.  Early evening dosing of ranitidine. Comparison with nighttime dosing of ranitidine or cimetidine in duodenal ulceration.

Authors:  J S Dixon; R S Ehsanullah; J G Mills; J R Wood
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

9.  Maintenance of intragastric pH > 4 with famotidine in duodenal ulcer patients: factors influencing drug requirements.

Authors:  J C Delchier; F Roudot-Thoraval; L Stanescu; M C Deharvengt; L Elouaer Blanc
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

10.  Postprandial biliary and pancreatic secretion during profound inhibition of gastric secretion in humans.

Authors:  A Lanzini; D Facchinetti; M G Pigozzi; A Wuhrer; A Saleri
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.